Safety and efficacy of a prescription digital therapeutic as an adjunct to buprenorphine for treatment of opioid use disorder

202045 citationsJournal Articlebronze Open Access

Authors

Yuri Maricich · Pear Therapeutics (United States)

Warren K. Bickel · Biomedical Research Institute

Lisa A. Marsch · Dartmouth College

Kirstin M. Gatchalian · Biomedical Research Institute

Jeffrey Botbyl

Hilary F. Luderer · Pear Therapeutics (United States)

Abstract

A prescription digital therapeutic (PDT) in combination with buprenorphine therapy improves clinically significant patient outcomes including abstinence from illicit opioids and retention in treatment compared with treatment as usual.

Topics & Keywords

Opioid Use Disorder Treatment Substance Abuse Treatment and Outcomes Digital Mental Health Interventions

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Current Medical Research and Opinion

Volume 37, Issue 2, pp. 167-173

DOI: 10.1080/03007995.2020.1846022

Field-Weighted Citation Impact: 4.97